Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
5948-5961
Author(s):
Sonja M. Kessler, Johannes Haybaeck and Alexandra K. Kiemer
Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Journal:
Current Stem Cell Research & Therapy
Volume:
12
Page:
37-44
Author(s):
Rohit P. Nagare, Smarakan Sneha, Syama Krishna Priya and Trivadi S. Ganesan
Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
4108-4134
Author(s):
José Portugal and Francisca Barceló
Indole-based, Antiproliferative Agents Targeting Tubulin Polymerization
Journal:
Current Topics in Medicinal Chemistry
Volume:
17
Page:
120-137
Author(s):
Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
17
Page:
44-50
Author(s):
Hao Liu, Haiyan Wang, Dingcheng Xiang and Wangang Guo
Autophagy in Diabetic Retinopathy
Journal:
Current Neuropharmacology
Volume:
14
Page:
810-825
Author(s):
Michelino Di Rosa, Gisella Distefano, Caterina Gagliano, Dario Rusciano and Lucia Malaguarnera
The Roles of Sox Family Genes in Sarcoma
Journal:
Current Drug Targets
Volume:
17
Page:
1761-1772
Author(s):
Jingyuan Li, Jacson Shen, Kunzheng Wang, Francis Hornicek and Zhenfeng Duan
Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
4830-4834
Author(s):
Li Cheng, Chongchong Wang and Juehua Jing
PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Journal:
Current Drug Targets
Volume:
17
Page:
1661-1672
Author(s):
Julia Alejandra Pezuk, Elvis Terci Valera and María Sol Brassesco
Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Journal:
Current Drug Targets
Volume:
17
Page:
1687-1703
Author(s):
Mahdi Shabani and Mohammad Hojjat-Farsangi